{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Boehringer Ingelheim GmbH", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Hikma Pharmaceuticals PLC", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Amman (Jordan)", "name": "glocations", "rank": "5", "is_major": "N"}, {"value": "Germany", "name": "glocations", "rank": "6", "is_major": "N"}, {"value": "United States", "name": "glocations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/11/business/dealbook/hikma-pharmaceuticals-cuts-offer-price-for-generic-drug-maker-roxane.html", "document_type": "article", "byline": {"person": [{"lastname": "BRAY", "firstname": "Chad", "role": "reported", "organization": "", "rank": 1}], "original": "By CHAD BRAY"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "394", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "pub_date": "2016-02-11T00:00:00Z", "news_desk": "Business", "headline": {"main": "Hikma Pharmaceuticals Cuts Offer Price for Generic Drug Maker Roxane"}, "print_page": null, "snippet": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "_id": "56bb077238f0d831a8916982", "slideshow_credits": null, "abstract": null}